Canine
Canine Facial Paralysis: Neurologic Localization and Diagnostic Workup
Bottom line
Treat canine facial paralysis as a localization problem before calling it idiopathic. Confirm CN VII motor dysfunction, assess corneal exposure and lacrimation immediately, then use associated vestibular, Horner, long-tract, and additional cranial-nerve signs to distinguish extracranial nerve, middle or inner ear, and brainstem disease.[1][2]
Confirm the deficit and exclude mimics
Observe facial symmetry at rest and during blinking, menace, nostril movement, ear movement, eating, and drinking. Unilateral facial paresis produces a widened palpebral fissure, drooping lip and pinna, reduced nostril movement, food retention, drooling, and deviation of the nasal planum away from the lesion. Chronic contracture can later reverse the apparent direction of asymmetry.[1]
Separate afferent trigeminal sensation from efferent facial movement. Loss of palpebral closure with preserved facial sensation supports CN VII dysfunction; reduced facial sensation or masticatory weakness expands localization to CN V or a more extensive lesion. Distinguish facial weakness from painful blepharospasm, enophthalmos, structural eyelid disease, muscle disease, and asymmetric conformation.
The paired owner guide helps capture onset and associated signs without unsafe home testing.
Protect the ocular surface on presentation
Evaluate spontaneous blink, palpebral closure, corneal clarity, fluorescein staining, and Schirmer tear testing. A proximal facial lesion may reduce parasympathetic input to the lacrimal gland while motor failure increases exposure, creating combined risk for neurogenic KCS and ulceration.[1]
Document baseline ocular findings and institute cause-appropriate corneal protection. Recheck frequency should reflect exposure, tear production, and epithelial integrity rather than the apparent stability of the facial deficit.
Localize with associated signs
Isolated facial paralysis with normal mentation, postural reactions, gait, and other cranial nerves favors a peripheral CN VII lesion. Ipsilateral head tilt, pathologic nystagmus, vestibular ataxia, or Horner syndrome with preserved mentation and limb function supports disease near the middle or inner ear, where CN VII travels beside CN VIII and sympathetic fibers.[1]
Altered mentation, ipsilateral proprioceptive deficits or paresis, multiple cranial-neuropathies, or central vestibular signs increase concern for a brainstem lesion. Perform a complete neurologic examination rather than stopping after the facial asymmetry.[2]
Build differentials by localization
For peripheral disease, prioritize otitis media or interna, trauma, iatrogenic injury, idiopathic facial neuritis, hypothyroidism-associated neuropathy, and neoplasia along the nerve or middle ear. Brainstem differentials include inflammatory, infectious, vascular, and neoplastic disease.[1]
A normal external canal does not exclude middle-ear disease. Conversely, otitis externa does not prove that the facial deficit originates in the ear. Pain on opening the mouth, vestibular signs, recurrent otitis, para-aural change, or progressive deficits strengthen the case for deeper imaging.[3]
Stage diagnostics
Minimum database and blood pressure testing are guided by age and systemic context. Thyroid testing is reasonable when compatible systemic or polyneuropathic features exist, but interpret total thyroxine in clinical context rather than assigning causality to an isolated low value.[4]
Perform otoscopy and cytology; culture should target appropriately collected material when bacterial middle-ear disease is suspected. CT provides strong evaluation of tympanic bullae and osseous change. MRI is preferred for brainstem localization, intracranial extension, and soft-tissue or facial-nerve assessment. CSF analysis and targeted infectious testing follow MRI when inflammatory central disease remains plausible.[1][3]
Electrodiagnostics can help characterize severity or chronicity in selected cases but do not replace etiologic investigation. Serial photographs and neurologic examinations provide a practical record of progression.
Avoid premature idiopathic labeling
Idiopathic facial paralysis is common in dogs, but the label is exclusionary. A stable isolated deficit after an appropriate otic, metabolic, neurologic, and imaging assessment is different from a progressive facial deficit with pain, vestibular signs, or other cranial-neuropathies. Re-localize if new deficits appear.
The acute vision-loss workup may help when menace is absent, but remember that menace requires vision, cerebellar integration, and facial motor function; facial paralysis alone can abolish the blink component.
Frequently Asked Questions
What finding most consistently supports canine facial paralysis?
Failure of active eyelid closure is the most consistent sign. Interpret the absent palpebral response by testing facial sensation separately because the afferent limb is trigeminal and the efferent limb is facial.
How does the neurologic examination separate peripheral from central disease?
Isolated ipsilateral facial paresis supports a peripheral CN VII lesion. Altered mentation, postural-reaction deficits, limb paresis, or additional cranial-nerve deficits increase concern for brainstem disease.
What pattern suggests middle- or inner-ear disease?
Facial paralysis accompanied by ipsilateral vestibular dysfunction or Horner syndrome with otherwise normal mentation and limb function localizes near the petrous temporal bone and middle or inner ear.
Which ocular tests are priorities?
Assess spontaneous and stimulated blinking, Schirmer tear testing, fluorescein staining, and the corneal surface. Exposure and neurogenic tear deficiency can coexist and require active protection.
When is advanced imaging warranted?
CT is useful for tympanic-bulla and osseous disease; MRI is preferred for brainstem, intracranial, and facial-nerve soft-tissue assessment. Image when localization, progression, pain, or concurrent deficits make idiopathic disease unsafe to assume.
Is idiopathic facial paralysis a diagnosis of exclusion?
Yes. It is considered when the deficit is isolated and investigation does not identify otic, metabolic, traumatic, neoplastic, inflammatory, or central disease.
References
Voyage Dispatch · thevoyage.ai/forvets/knowledge/canine-facial-paralysis-neurologic-localization-workup · published Sep 27, 2026 · verify dosing against the current formulary before prescribing
More clinical updates
Canine Acute Vision Loss: Localization and Diagnostic Workup
A localization-first approach to acute canine blindness, separating opaque media, retinal dysfunction, optic-nerve disease, and central visual pathway lesions.
Read →Phenobarbital for Canine Idiopathic Epilepsy: Prescribing Patterns, Pharmacometrics, and TDM
Phenobarbital remains the most-prescribed first-line ASD for canine idiopathic epilepsy (34.9% in US primary care). A 2025 population PK model enables precision dosing, while TDM to a 20-35 ug/mL target stays essential and is itself assay-dependent.
Read →Cannabidiol (CBD) for Canine Idiopathic Epilepsy: What the Controlled Trials Show
Two randomized trials and a pilot cohort show CBD added to antiseizure drugs modestly cuts seizure frequency in dogs, but not the 50%-responder rate; ALP rises consistently, so monitor the liver and watch CYP450 interactions.
Read →Zonisamide for Canine Idiopathic Epilepsy: Efficacy, Tolerability, and Therapeutic Drug Monitoring
Evidence review for veterinarians: a 207-dog TDM cohort proposes a 10-55 mcg/mL canine reference interval and 76% of newly-diagnosed dogs reached >=50% seizure reduction on monotherapy, with feline tolerability signals from a 57-cat cohort.
Read →